IDO1 and neoplasm: IDO is expressed constitutively by tumor cells or by host immune cells such as macrophages and DCs in the tumor or lymph nodes [42, 43], but can also be induced by inflammatory cytokines such as IFN-γ during a tumor directed immune response, potentially mitigating the effectiveness of immunotherapy [44].